Given the key role of LKB1 in the regulation of cell metabolism, we investigated in KRASmut/LKB1mut NSCLC (KL) preclinical models whether the introduction of metabolic stressors like metformin and caloric restriction, in combination with current therapies, could lead to a better tumor response. This evidence concerns the gene STK11 and neoplasm.